Hebert LA - Search Results

1

Management of glomerular proteinuria: a commentary.

Wilmer WA, Rovin BH, Hebert CJ, Rao SV, Kumor K, Hebert LA. Wilmer WA, et al. Among authors: hebert la, hebert cj. J Am Soc Nephrol. 2003 Dec;14(12):3217-32. doi: 10.1097/01.asn.0000100145.27188.33. J Am Soc Nephrol. 2003. PMID: 14638920 Review.

2

Urine chemokines as biomarkers of human systemic lupus erythematosus activity.

Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN. Rovin BH, et al. Among authors: hebert la. J Am Soc Nephrol. 2005 Feb;16(2):467-73. doi: 10.1681/ASN.2004080658. Epub 2004 Dec 15. J Am Soc Nephrol. 2005. PMID: 15601744

3

Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.

Birmingham DJ, Rovin BH, Shidham G, Bissell M, Nagaraja HN, Hebert LA. Birmingham DJ, et al. Among authors: hebert la. Clin J Am Soc Nephrol. 2008 Jul;3(4):1028-33. doi: 10.2215/CJN.04761107. Epub 2008 May 1. Clin J Am Soc Nephrol. 2008. PMID: 18450925 Free PMC article.

4

Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Hebert LA, Parikh S, Prosek J, Nadasdy T, Rovin BH. Hebert LA, et al. Am J Nephrol. 2013;38(3):253-66. doi: 10.1159/000354390. Epub 2013 Sep 13. Am J Nephrol. 2013. PMID: 24052039 Free PMC article. Review.

5

The Urine Preservative Acetic Acid Degrades Urine Protein: Implications for Urine Biorepositories and the AASK Cohort Study.

Almaani S, Hebert LA, Rovin BH, Birmingham DJ. Almaani S, et al. Among authors: hebert la. J Am Soc Nephrol. 2017 May;28(5):1394-1398. doi: 10.1681/ASN.2016080886. Epub 2017 Jan 19. J Am Soc Nephrol. 2017. PMID: 28104821 Free PMC article.

6

Mycophenolate therapy of SLE membranous nephropathy.

Spetie DN, Tang Y, Rovin BH, Nadasdy T, Nadasdy G, Pesavento TE, Hebert LA. Spetie DN, et al. Among authors: hebert la. Kidney Int. 2004 Dec;66(6):2411-5. doi: 10.1111/j.1523-1755.2004.66030.x. Kidney Int. 2004. PMID: 15569333 Free article. Clinical Trial.

7

The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.

Hebert LA, Rovin BH, Hebert CJ. Hebert LA, et al. Among authors: hebert cj. Nat Clin Pract Nephrol. 2007 Feb;3(2):60-1. doi: 10.1038/ncpneph0391. Nat Clin Pract Nephrol. 2007. PMID: 17251990 No abstract available.

8

Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option.

McKinley A, Park E, Spetie D, Hackshaw KV, Nagaraja S, Hebert LA, Rovin BH. McKinley A, et al. Among authors: hebert la. Clin J Am Soc Nephrol. 2009 Nov;4(11):1754-60. doi: 10.2215/CJN.02670409. Epub 2009 Sep 3. Clin J Am Soc Nephrol. 2009. PMID: 19729427 Free PMC article.

9

Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care?

Hebert LA, Rovin BH. Hebert LA, et al. Nephron Clin Pract. 2011;117(1):c8-14. doi: 10.1159/000319641. Epub 2010 Aug 3. Nephron Clin Pract. 2011. PMID: 20689319 Free PMC article. Review.

10

An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis.

Ardoin S, Birmingham DJ, Hebert PL, Yu CY, Rovin BH, Hebert LA. Ardoin S, et al. Among authors: hebert pl, hebert la. Arthritis Rheum. 2011 Jul;63(7):2031-7. doi: 10.1002/art.30345. Arthritis Rheum. 2011. PMID: 21400484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters